Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

NCT00814216 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: QAV680
DRUG: Matching placebo for QAV680
DRUG: Fluticasone Propionate

Sponsor

Novartis